Opportunity Information: Apply for HRSA 22 029
Emerging Strategies to Improve Health Outcomes for People Aging with HIV: Evaluation Provider (HRSA 22-029) is a discretionary cooperative agreement funding opportunity from the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA), under CFDA 93.928. It was created on October 26, 2021, with an original closing date of January 25, 2022. HRSA anticipated making one award under this specific notice. The award ceiling is listed as 0 in the source data, which typically signals that applicants should rely on the full announcement for budget expectations and constraints rather than a fixed published cap in the summary field. Eligibility is broadly described as "Others," with additional eligibility details referenced in the full notice.
This opportunity is one part of a three-piece national initiative focused on improving health outcomes for people living with HIV who are age 50 and older. The overall initiative funds (1) a capacity-building provider (HRSA-22-027), (2) multiple demonstration sites (HRSA-22-028), and (3) this evaluation provider (HRSA-22-029). The evaluation provider is meant to function as the cross-site learning and assessment backbone of the project, working in close coordination with the capacity-building organization and the funded demonstration sites. Because the funding instrument is a cooperative agreement, HRSA expects substantial federal involvement during the project period, meaning the awardee will collaborate actively with HRSA rather than operating with minimal federal interaction.
The work across all three components is organized around the HRSA HIV/AIDS Bureau (HAB) Implementation Science Framework (HAB IS). In practical terms, that means the initiative is not only about introducing promising clinical and service delivery approaches, but also about systematically studying how those approaches are adopted, integrated, and sustained in real-world HIV care settings. The emerging strategies to be implemented are centered on comprehensive screening and management for issues that commonly affect older adults with HIV, including comorbid medical conditions, geriatric conditions, behavioral health concerns, and psychosocial needs. The target population is explicitly people aged 50 and older with HIV, reflecting the growing number of individuals who are living longer with HIV and experiencing more complex, age-associated health and social service needs.
As the evaluation provider, the awardee is expected to assess how well these emerging strategies are taken up and incorporated into routine practice across the demonstration sites. That includes examining the degree of integration into workflows and service models, identifying what is working and what is not, and determining where implementation support or adaptation is needed. The evaluation scope also emphasizes understanding the implementation process itself, including analyzing which specific implementation strategies are used (for example, training approaches, workflow redesign, clinical decision supports, partnerships, or referral pathways) and how those strategies influence adoption and fidelity.
A major element of the evaluation role is documenting the broader contextual factors that shape implementation success or challenges. These contextual influences can include organizational capacity, staffing and workforce constraints, clinic infrastructure, community resources, patient demographics and needs, local policy environments, and other real-world conditions that affect whether an intervention can be delivered as intended and sustained over time. Alongside process and context evaluation, the initiative calls for assessing the impact of the emerging strategies, meaning the evaluation provider should help determine what changes occur as a result of implementation, such as improvements in screening rates, better management of comorbidities, stronger behavioral health connections, improved psychosocial supports, and ultimately better health outcomes for older people with HIV.
Finally, the initiative places clear value on translating learning into practice beyond the funded sites. The evaluation provider is therefore expected to support documentation, synthesis, and dissemination of the emerging strategies and lessons learned, helping HRSA and the broader HIV service community understand what was implemented, how it was implemented, under what conditions it worked best, and what other programs would need to replicate or adapt the approaches. In short, HRSA 22-029 funds a single entity to serve as the central evaluator and learning partner within a coordinated national effort, ensuring that implementation is rigorously studied and that practical, transferable knowledge is produced for improving care for people aging with HIV.Apply for HRSA 22 029
- The Department of Health and Human Services, Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Emerging Strategies to Improve Health Outcomes for People Aging with HIV: Evaluation Provider" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.928.
- This funding opportunity was created on Oct 26, 2021.
- Applicants must submit their applications by Jan 25, 2022. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the "Emerging Strategies to Improve Health Outcomes for People Aging with HIV: Evaluation Provider" opportunity (HRSA 22-029)?
HRSA 22-029 is a discretionary cooperative agreement funding opportunity from the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA). It funds a single organization to serve as the central evaluation and cross-site learning partner for a national initiative focused on improving health outcomes for people living with HIV who are age 50 and older.
Which agency is offering this funding?
The funding is offered by HRSA, an agency within HHS, specifically aligned with the HRSA HIV/AIDS Bureau (HAB).
What is the assistance listing / CFDA number for this opportunity?
The opportunity is listed under CFDA 93.928.
What type of funding instrument is HRSA 22-029?
This opportunity uses a cooperative agreement. That means HRSA expects substantial federal involvement during the project period, with active collaboration between HRSA and the awardee rather than limited federal interaction.
How many awards did HRSA anticipate making under this specific notice?
HRSA anticipated making one award under HRSA 22-029.
When was HRSA 22-029 created, and what was the original closing date?
The opportunity was created on October 26, 2021, and the original closing date was January 25, 2022.
What does the award ceiling of "0" mean in the summary data?
The source data lists the award ceiling as 0, which typically signals that applicants should rely on the full funding announcement for budget expectations and constraints rather than assuming there is a fixed published cap in the summary field.
Who is eligible to apply?
Eligibility is broadly described as "Others." Additional eligibility requirements and details are referenced in the full notice.
How does HRSA 22-029 fit into the larger national initiative?
HRSA 22-029 is one component of a three-part national initiative focused on improving health outcomes for people living with HIV who are age 50 and older. The initiative includes: (1) a capacity-building provider (HRSA-22-027), (2) multiple demonstration sites (HRSA-22-028), and (3) this evaluation provider (HRSA-22-029).
What is the main purpose of the evaluation provider in this initiative?
The evaluation provider serves as the cross-site learning and assessment backbone of the project. The role is to evaluate how emerging strategies are implemented across the demonstration sites, understand what supports or adaptations are needed, assess outcomes and impacts, and help translate lessons learned into practical knowledge that can be used beyond the funded sites.
Who is the target population for the strategies being evaluated?
The target population is people living with HIV who are age 50 and older, reflecting the growing number of individuals aging with HIV and experiencing more complex, age-associated health and social service needs.
What kinds of issues do the emerging strategies focus on for older adults with HIV?
The strategies center on comprehensive screening and management for issues that commonly affect older adults with HIV, including comorbid medical conditions, geriatric conditions, behavioral health concerns, and psychosocial needs.
What framework guides the work across the initiative?
The work is organized around the HRSA HIV/AIDS Bureau (HAB) Implementation Science Framework (HAB IS). This emphasizes not only implementing promising approaches, but also systematically studying how they are adopted, integrated, and sustained in real-world HIV care settings.
What does HRSA expect the evaluation provider to assess at demonstration sites?
The evaluation provider is expected to assess how well the emerging strategies are taken up and incorporated into routine practice. This includes examining integration into workflows and service models, identifying what is working and what is not, and determining where implementation support or adaptation is needed.
Is the evaluation focused only on outcomes, or also on implementation process?
It includes both. The scope emphasizes understanding the implementation process itself (how strategies are adopted and integrated) as well as assessing the impact of the strategies (what changes occur as a result of implementation).
What are examples of implementation strategies the evaluation may examine?
The evaluation may analyze which implementation strategies are used across sites, such as training approaches, workflow redesign, clinical decision supports, partnerships, or referral pathways, and how these influence adoption and fidelity.
What are "contextual factors," and why are they important in this evaluation?
Contextual factors are real-world conditions that shape whether an intervention can be delivered as intended and sustained over time. The evaluation is expected to document influences such as organizational capacity, staffing and workforce constraints, clinic infrastructure, community resources, patient demographics and needs, local policy environments, and other conditions affecting implementation success or challenges.
What kinds of impacts is the initiative aiming to measure?
The evaluation is intended to help determine what changes occur from implementing the emerging strategies, such as improvements in screening rates, better management of comorbidities, stronger behavioral health connections, improved psychosocial supports, and ultimately better health outcomes for older people with HIV.
How will the evaluation findings be used beyond the funded sites?
A key expectation is to support documentation, synthesis, and dissemination of the emerging strategies and lessons learned. The goal is to help HRSA and the broader HIV service community understand what was implemented, how it was implemented, under what conditions it worked best, and what other programs would need to replicate or adapt the approaches.
Who will the evaluation provider coordinate with during the project?
The evaluation provider is meant to work in close coordination with the capacity-building organization and the funded demonstration sites, while also collaborating actively with HRSA due to the cooperative agreement structure.
What does it mean that this is a cross-site evaluation and learning role?
It means the awardee is expected to look across multiple demonstration sites, assess patterns and differences in implementation and outcomes, and synthesize lessons that can inform improvements during the project and support broader replication or adaptation later.
What does "integration into routine practice" refer to in this opportunity?
It refers to whether the emerging strategies become part of normal clinic workflows and service delivery models at demonstration sites, rather than remaining stand-alone or temporary activities.
What does "fidelity" mean in the context of this evaluation?
In this context, fidelity refers to how closely the demonstration sites implement the emerging strategies as intended, and how implementation strategies may influence consistency and quality of delivery.
Browse more opportunities from the same category: Health
Next opportunity: Large Grants NOFO
Previous opportunity: Opportunity title from S2S
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 22 029
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 22 029) also looked into and applied for these:
| Funding Opportunity |
|---|
| National Hemophilia Program Coordinating Center Apply for HRSA 22 079 Funding Number: HRSA 22 079 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Regional Hemophilia Network Apply for HRSA 22 068 Funding Number: HRSA 22 068 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Fiscal Year 2022 Health Center Controlled Networks Apply for HRSA 22 009 Funding Number: HRSA 22 009 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Title X Family Planning Services Grants Apply for PA FPH 22 001 Funding Number: PA FPH 22 001 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $22,000,000 |
| Maternal and Child Health Secondary Data Analysis Research (MCH SDAR) Apply for HRSA 22 096 Funding Number: HRSA 22 096 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations Apply for CDC RFA DP22 2202 Funding Number: CDC RFA DP22 2202 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $8,000,000 |
| Implementing Pre-exposure Prophylaxis for HIV Prevention in Syringe Service Programs Apply for RFA PS 22 001 Funding Number: RFA PS 22 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $625,000 |
| Rural Health Network Development Planning Program Apply for HRSA 22 059 Funding Number: HRSA 22 059 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| Ryan White HIV/AIDS Program Part D Coordinated HIV Services and Access to Research for Women, Infants, Children, and Youth (WICY) Existing Geographic Service Areas Apply for HRSA 22 037 Funding Number: HRSA 22 037 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Health Systems for Quality Health Services:Activity 5 - USAID Human Resources for Health (HRH), Quality Management and Community Health Systems Apply for 72061521RFA00019 Funding Number: 72061521RFA00019 Agency: Agency for International Development, Kenya USAID-Nairobi Category: Health Funding Amount: $15,000,000 |
| Health Sector Financing: Activity 2 - Health Financing Analytics and Social Protection Systems for Health and Activity 3 - Private Sector Engagement. Apply for 72061521RFA00020 Funding Number: 72061521RFA00020 Agency: Agency for International Development, Kenya USAID-Nairobi Category: Health Funding Amount: $27,500,000 |
| Health Systems Leadership: Activity 1 - Health Sector Governance and Strategic Partnerships Apply for 72061521RFA00021 Funding Number: 72061521RFA00021 Agency: Agency for International Development, Kenya USAID-Nairobi Category: Health Funding Amount: $27,500,000 |
| Centers of Excellence (COE) Apply for HRSA 22 042 Funding Number: HRSA 22 042 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $686,000 |
| Community Led Monitoring-Routine Data Collection and Provider feedback Apply for DOS NBO PCO FY22 001 Funding Number: DOS NBO PCO FY22 001 Agency: Department of State, U.S. Mission to Kenya Category: Health Funding Amount: $200,000 |
| Community Led Monitoring-Routine Data Collection and Provider feedback Apply for DOS NBO PCO FY22 002 Funding Number: DOS NBO PCO FY22 002 Agency: Department of State, U.S. Mission to Kenya Category: Health Funding Amount: $400,000 |
| Leadership Education in Adolescent Health (LEAH) Program Apply for HRSA 22 072 Funding Number: HRSA 22 072 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Domestic Violence Prevention Program: Forensic Healthcare Services Apply for HHS 2022 IHS FHC 0001 Funding Number: HHS 2022 IHS FHC 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $250,000 |
| Domestic Violence Prevention Program Apply for HHS 2022 IHS DVP 0001 Funding Number: HHS 2022 IHS DVP 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $200,000 |
| Behavioral Health Integration Initiative Apply for HHS 2022 IHS BH2I 0001 Funding Number: HHS 2022 IHS BH2I 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $400,000 |
| Substance Abuse and Suicide Prevention Program: Suicide Prevention, Intervention, and Postvention Apply for HHS 2022 IHS SPIP 0001 Funding Number: HHS 2022 IHS SPIP 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $400,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 22 029", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
